> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# MOU Period Extended for Compounded Drugs
- URL: https://www.fdaweb.com/mou-period-extended-for-compounded-drugs/
- Published: 2021-08-06T12:00:00.000Z
- Updated: 2026-09-14T17:09:35.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149882

*Federal Register* notice: FDA is extending the period for states to decide whether to sign the final standard memorandum of understanding (MOU) entitled “Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products Between the \[insert State Board of Pharmacy or Other Appropriate State Agency\] and the U.S. Food and Drug Administration” before the agency intends to begin enforcing the statutory 5% limit on distribution of compounded human drug products out of the state in which they are compounded in states that do not sign the final standard MOU. The period was scheduled to end on 10/27 and now is extended until 10/27/2022\. To view the notice, click [here](https://public-inspection.federalregister.gov/2021-16937.pdf?ref=fdaweb.com).